A propensity score-matched analysis of neoadjuvant chemoimmunotherapy versus surgery alone for locally advanced esophageal squamous cell carcinoma.

Kexi WangYicheng LiangJing HuangXuan XieDuoguang WuBaishen ChenKefeng WangZhuojian ShenYuquan LiWenjian WangXueting HuMinghui Wang

Published in: Journal of surgical oncology (2023)

Overall, NICT followed by esophagectomy appears to be safe and feasible for locally advanced ESCC. However, further multicenter prospective clinical trials are needed to validate our results.

Keyphrases

clinical trial
minimally invasive
rectal cancer
coronary artery bypass
lymph node
double blind
locally advanced
robot assisted
cross sectional
surgical site infection
phase ii
randomized controlled trial
open label
percutaneous coronary intervention
radiation therapy
atrial fibrillation
squamous cell carcinoma